"The personalisation of cancer treatments is leading to better outcomes for patients"

As Glenn Reynolds writes frequently, "Faster, please."

David Karow, a clinical radiologist who works both there and at the nearby San Diego campus of the University of California, is optimistic about the potential of the technique for wider use. He has been part of a study published recently in Clinical Cancer Research that suggests MRI might become the standard method for prostate-cancer screening. His research suggests it can differentiate between benign tumours, which just need to be monitored, and aggressive ones that need to be treated. 

Related: "Simple blood tests can help detect, target cancer"

"The Immortality Hype: Despite the hyperbole, private funding is changing the science of aging for the better."

Lots of private money will be needed because of federal government dopiness:

NIH review panels “tend to be conservative because there isn’t a lot of money and they like to fund things that are certain to succeed,” says David Sinclair, a professor of genetics at Harvard Medical School, and co-director of the Paul F. Glenn Center for the Biological Mechanisms of Aging, a wing of the Glenn Foundation for Medical Research, one of the largest private funders of aging research.

More on what the private sector can do: "Rising health care costs spurring innovation".

"More Men With Early Prostate Cancer Are Choosing to Avoid Treatment"

Interesting. Especially this:

In recent years, major research organizations have begun to recommend active surveillance, which for years had been promoted mostly by academic urologists in major medical centers, but not by urologists in private practice, who treat most men.

Trust the academics or the private practice folks?

And then there's Instapundit's comment: "I'm not saying this is a bad idea, but I'm suspicious they only started touting stuff like this once Obamacare passed."